JENNIFER M GARRISON
Allopathic & Osteopathic Physicians|Family Medicine KATY, TX NPI 1396901138
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX Abbott Laboratories All categories
General Payments — all program years on this page
$7,835.43
- Category: General Payments
- Program years: PY2018–2024
- Record count: 455
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,792.01 across 96 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,759.74 | 95 |
| Education | $32.27 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $337.27 | 22 |
| Novo Nordisk AS | $320.31 | 26 |
| Corcept Therapeutics | $280.49 | 5 |
| DEXCOM, INC. | $94.68 | 4 |
| ABBVIE INC. | $93.66 | 4 |
| PFIZER INC. | $79.43 | 4 |
| Lilly USA, LLC | $77.39 | 4 |
| Acerta Pharma LLC | $69.37 | 4 |
| Exact Sciences Corporation | $62.18 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $61.03 | 3 |
| Astellas Pharma US Inc | $56.28 | 3 |
| Verity Pharmaceuticals Inc. | $48.77 | 2 |
| Amgen Inc. | $37.39 | 2 |
| TOLMAR, INC. | $32.94 | 2 |
| Currax Pharmaceuticals LLC | $30.91 | 2 |
| GlaxoSmithKline, LLC. | $23.37 | 1 |
| Inspire Medical Systems, Inc. | $21.00 | 1 |
| Azurity Pharmaceuticals, Inc. | $19.94 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $17.33 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.65 | 1 |
| Esperion Therapeutics, Inc. | $13.62 | 1 |
By program year
Records — PY2024 (96)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.